Compounds > pyrroles

Page last updated: 2024-08-18

pyrroles and ritonavir

pyrroles has been researched along with ritonavir in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (15.38)	18.2507
2000's	7 (53.85)	29.6817
2010's	3 (23.08)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Henry, K; Hermundson, J; Huebesch, J; Melroe, H; Simpson, J	1
Martín, T; Murillas, J; Portero, JL; Ramos, A	1
Aberg, JA; Alston, B; Aweeka, F; Blaschke, T; Fang, F; Fichtenbaum, CJ; Gerber, JG; Kosel, B; Rosenkranz, SL; Segal, Y	1
Piliero, PJ	1
Gill, MJ; Mah Ming, JB	1
Hochman, JH; Lin, JH; Prueksaritanont, T; Pudvah, N; Qiu, J; Tang, C; Yamazaki, M	1
Hirsch, RL	1
Gaughan, JP; Klibanov, OM; Tedaldi, EM; van den Berg-Wolf, M	1
Barditch-Crovo, P; Cameron, DW; Elgadi, MM; Flexner, C; Fuchs, E; la Porte, CJ; Lee, LS; Pham, PA; Piliero, PJ; Sabo, JP; van Heeswijk, R	1
Schmidt, C	1
de Serres, M; Gould, E; Johnson, M; Kim, J; Lou, Y; Mayers, D; Pietropaolo, K; Piscitelli, S; White, S; Zhou, XJ	1
Aboulafia, D; Cianfrocca, ME; Deeken, JF; Dezube, BJ; Dowlati, A; Gerecitano, J; Haigentz, M; Henry, DH; Ivy, SP; Little, RF; Mitsuyasu, RT; Moore, PC; Ratner, L; Rudek, MA; Sullivan, R	1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M	1

Trials

4 trial(s) available for pyrroles and ritonavir

Article	Year
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS (London, England), 2002, Mar-08, Volume: 16, Issue:4 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Drug Interactions; Heptanoic Acids; HIV Protease Inhibitors; HIV Seronegativity; Human Experimentation; Humans; Pravastatin; Pyrroles; Ritonavir; Saquinavir; Simvastatin	2002
Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Atorvastatin; Drug Interactions; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Middle Aged; Pyridines; Pyrimidines; Pyrones; Pyrroles; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Young Adult	2009
Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor. British journal of clinical pharmacology, 2012, Volume: 74, Issue:2 Topics: Adenine; Androstenes; Anti-HIV Agents; Atazanavir Sulfate; Atorvastatin; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Interactions; Emtricitabine; Ethinyl Estradiol; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Least-Squares Analysis; Linear Models; Lopinavir; Male; Oligopeptides; Organophosphonates; Patient Safety; Phosphinic Acids; Pyridines; Pyrimidines; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Risk Assessment; Ritonavir; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tenofovir	2012
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061. Cancer, 2014, Apr-15, Volume: 120, Issue:8 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; HIV Infections; Humans; Indoles; Male; Middle Aged; Neoplasms; Pyrroles; Ritonavir; Sunitinib	2014

Other Studies

9 other study(ies) available for pyrroles and ritonavir

Article	Year
Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet (London, England), 1998, Sep-26, Volume: 352, Issue:9133 Topics: Anticholesteremic Agents; Atorvastatin; Drug Therapy, Combination; Gemfibrozil; Heptanoic Acids; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Protease Inhibitors; Pyrroles; Ritonavir; Saquinavir	1998
Atorvastatin for protease inhibitor-related hyperlipidaemia. AIDS (London, England), 1999, Jul-30, Volume: 13, Issue:11 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Drug Therapy, Combination; Female; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Male; Pyrroles; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir	1999
Interaction between ritonavir and statins. The American journal of medicine, 2002, Apr-15, Volume: 112, Issue:6 Topics: Atorvastatin; Cytochrome P-450 Enzyme System; Drug Interactions; Heptanoic Acids; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Ritonavir; Simvastatin	2002
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS patient care and STDs, 2003, Volume: 17, Issue:5 Topics: Adult; Anti-Bacterial Agents; Atorvastatin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Male; Pyrimidinones; Pyrroles; Rhabdomyolysis; Ritonavir	2003
Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin. Pharmaceutical research, 2004, Volume: 21, Issue:9 Topics: Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Line; Drug Interactions; Heptanoic Acids; Humans; Hypolipidemic Agents; Pyrroles; Ritonavir; Simvastatin; Time Factors	2004
Torcetrapib and atorvastatin. The New England journal of medicine, 2005, Oct-06, Volume: 353, Issue:14 Topics: Atorvastatin; Drug Costs; Drug Industry; Heptanoic Acids; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Quinolines; Ritonavir	2005
Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients. AIDS patient care and STDs, 2008, Volume: 22, Issue:6 Topics: Adult; Anticholesteremic Agents; Antiretroviral Therapy, Highly Active; Atorvastatin; Azetidines; Cholesterol, LDL; Drug Administration Schedule; Ezetimibe; Female; Follow-Up Studies; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypercholesterolemia; Lopinavir; Male; Middle Aged; Pilot Projects; Pravastatin; Prospective Studies; Pyrroles; Ritonavir; Treatment Outcome	2008
The cancer-HIV/AIDS treatment conundrum. Journal of the National Cancer Institute, 2010, Nov-03, Volume: 102, Issue:21 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Cytochrome P-450 CYP3A; Drug Administration Schedule; Drug Antagonism; HIV Infections; HIV Protease Inhibitors; Humans; Indoles; Neoplasms; Pyrroles; Risk Factors; Ritonavir; Sunitinib	2010
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196 Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines	2021